Overview Study of SCB01A in Patient With Head and Neck Cancer Status: Terminated Trial end date: 2017-12-01 Target enrollment: Participant gender: Summary To evaluate the safety and efficacy of SCB01A in head and neck cancer. Phase: Phase 2 Details Lead Sponsor: SynCore Biotechnology Co., Ltd.